References
- Al-Jamal WT, Al-Ahmady ZS, Kostarelos K. (2012). Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia. Biomaterials 33:4608–17
- Celia C, Trapasso E, Cosco D, et al (2009). Turbiscan Lab® Expert analysis of the stability of ethosomes® and ultradeformable liposomes containing a bilayer fluidizing agent. Colloids Surf B Biointerfaces 72:155–60
- Dandamudi S, Campbell RB. (2007). The drug loading, cytotoxicty and tumor vascular targeting characteristics of magnetite in magnetic drug targeting. Biomaterials 28:4673–83
- Fischer PM, Zhelev NZ, Wang S, et al (2000). Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin. J Pept Res 55:163–72
- Gabizon A, Shmeeda H, Horowitz AT, Zalipsky S. (2004). Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. Adv Drug Deliv Rev 56:1177–92
- Kim CS, Duncan B, Creran B, Rotello VM. (2013). Triggered nanoparticles as therapeutics. Nano Today 8:439–47
- Kirpotin D, Drummond D, Shao Y, et al (2006). Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res 66:6732–40
- Krate F, Abu Ajaj K, Warnecke A. (2007). Anticancer carrier-linked prodrugs in clinical trials. Expert Opin Investig Drugs 16:1037–58
- Kulshrestha P, Gogoi M, Bahadur D, Banerjee R. (2012). In vitro application of paclitaxel loaded magnetoliposomes for combined chemotherapy and hyperthermia. Colloids Surf B Biointerfaces 96:1–7
- Kurrikoff K, Gestin M, Langel Ü. (2016). Recent in vivo advances in cell-penetrating peptide-assisted drug delivery. Expert Opin Drug Deliv 13:373–87
- Lin W, Xie XY, Liu H, et al (2016). Cell-penetrating peptide-doxorubicin conjugate loaded NGR-modified nanobubbles for ultrasound triggered drug delivery. J Drug Target 24:134–46
- Marianecci C, Paolino D, Celia C, et al (2010). Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts. J Control Release 147:127–35
- Pradhan P, Giri J, Rieken F, et al (2010). Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. J Control Release 142:108–21
- Shi NQ, Gao W, Xiang B, Qi XR. (2012). Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage. Int J Nanomedicine 7:1613–21
- Taghizadeh B, Taranejoo S, Monemian SA, et al (2015). Classification of stimuli-responsive polymers as anticancer drug delivery systems. Drug Deliv 22:145–55
- Torchilin VP. (2000). Drug targeting. Eur J Pharm Sci 11:S81–91
- Torchilin VP. (2007). Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J 9:E128–47
- Viglianti BL. (2009). Target molecular therapies: methods to enhance and monitor tumor drug delivery. Abdom Imaging 34:686–95
- Xie XY, Lin W, Liu H, et al (2015a). Ultrasound-responsive nanobubbles contained with peptide-camptothecin conjugates for targeted drug delivery. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.2015.1077289
- Xie XY, Yang YF, Lin W, et al (2015b). Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ultrasound triggered siRNA delivery. Colloids Surf B Biointerfaces 136:641–50
- Yang Y, Yang YF, Xie XY, et al (2015). Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery. Biomaterials 48:84–96
- Yang YF, Yang Y, Xie XY, et al (2014). PEGylated liposomes with NGR ligand and heat-activable cell penetrating peptide-doxorubicin conjugate for tumor-specific therapy. Biomaterials 35:4368–81